Growth Metrics

Sarepta Therapeutics (SRPT) EBT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.79%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 47.54%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -49.71%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 12.01%
7 Evaxion A 62.56 Bn 62.54 Bn - 20.92%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -1.05%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67%
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn 38.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 38.72%
Dec 31, 2025 -41.37%
Sep 30, 2025 8.87%
Jun 30, 2025 38.79%
Mar 31, 2025 -54.42%
Dec 31, 2024 45.38%
Sep 30, 2024 39.42%
Jun 30, 2024 29.39%
Mar 31, 2024 30.99%
Dec 31, 2023 51.55%
Sep 30, 2023 44.72%
Jun 30, 2023 54.10%
Mar 31, 2023 -209.01%
Dec 31, 2022 50.89%
Sep 30, 2022 -26.69%
Jun 30, 2022 6.18%
Mar 31, 2022 -10.80%
Dec 31, 2021 19.37%
Sep 30, 2021 14.66%
Jun 30, 2021 9.04%
Mar 31, 2021 -68.13%
Dec 31, 2020 -93.94%
Sep 30, 2020 -62.56%
Jun 30, 2020 -33.66%
Mar 31, 2020 -30.10%
Dec 31, 2019 -38.50%
Sep 30, 2019 -30.50%
Jun 30, 2019 -64.28%
Mar 31, 2019 -8.60%
Dec 31, 2018 -30.02%
Sep 30, 2018 -14.19%
Jun 30, 2018 -37.16%
Mar 31, 2018 17.12%
Dec 31, 2017 16.71%
Sep 30, 2017 -10.73%
Jun 30, 2017 -27.78%
Mar 31, 2017 75.73%
Dec 31, 2016 -39.12%
Sep 30, 2016 -31.65%
Jun 30, 2016 -53.86%
Mar 31, 2016 -57.91%
Dec 31, 2015 -84.38%
Sep 30, 2015 -96.35%
Jun 30, 2015 -97.69%
Mar 31, 2015 -108.98%
Dec 31, 2014 -71.58%
Sep 30, 2014 -44.89%
Jun 30, 2014 -44.78%
Mar 31, 2014 -66.51%
Dec 31, 2013 -170.97%
Sep 30, 2013 -88.47%
Jun 30, 2013 -30.96%